(Q36179765)

12 August 2017

Topotecan, an active new antineoplastic agent: review and current status (English)

1 reference

12 August 2017

Carmichael J

1

1 reference

PubMed ID

15989623

12 August 2017

Ozols RF

series ordinal

2

1 reference

PubMed ID

15989623

12 August 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

Expert Opinion on Investigational Drugs

12 August 2017

1 reference

12 August 2017

6

1 reference

12 August 2017

5

1 reference

12 August 2017

593-608

1 reference

Topoisomerase I inhibitors: topotecan and irenotecan

12 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.5.593

Emerging drug treatments for solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.5.593

Nucleotide sequence preference at rat liver and wheat germ type 1 DNA topoisomerase breakage sites in duplex SV40 DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.5.593

Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.5.593

Successful local regional therapy with topotecan of intraperitoneally growing human ovarian carcinoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.5.593

Sequential administration of camptothecin and etoposide circumvents the antagonistic cytotoxicity of simultaneous drug administration in slowly growing human colon carcinoma HT-29 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.5.593

Phase I clinical and pharmacology study of topotecan given daily for 5 consecutive days to patients with advanced solid tumors, with attempt at dose intensification using recombinant granulocyte colony-stimulating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.5.593

Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.5.593

Phase II trial of topotecan in patients with cisplatin-refractory germ cell tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.5.593

Activity of docetaxel (Taxotere) in small cell lung cancer. The Early Clinical Trials Group of the EORTC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.6.5.593

21 January 2018

Identifiers

DOI

10.1517/13543784.6.5.593

1 reference

12 August 2017

1 reference

PubMed ID

15989623